British ruled India for 170 years, looted us, now an Indian is richest person in Britain, richer than Queen, net worth is Rs..., name is...
New Delhi: It is said that the British ruled over India for nearly 200 years and took away a huge amount of wealth and property from here. Despite such a massive looting by the British, today the richest person in Britain is an Indian.
This Indian family residing in Britain possesses more wealth than even the Queen of England, and throughout Britain, this family's influence is significant. The Times Magazine's Rich List 2025 has once again chosen this Indian family as number 1.
At the top of the Times Rich List 2025 is the name of Gopichand Hinduja and his family. This family has approximately 33.67 lakh crore rupees in assets. They have left behind the David and Simon Reuben family, who are in second place, by a margin of 8 thousand crore rupees. This family is the owner of the multinational company Hinduja Group, which operates in trucking, lubricant, banking, and cable television sectors. About Gopichand Hinduja
Gopichand works as the chairman of the Hinduja Group. He assumed this position in May 2023 after the death of his older brother, Srichand Hinduja. The Hinduja family also holds a strong foothold in the real estate sector in London, where the most famous property is the Raffles London Hotel, located in the historic Old War Office building in Whitehall. Graduation from India
Gopichand Hinduja completed his graduation in 1959 from Jai Hind College in Mumbai. After that, he obtained a doctorate in law from Westminster University. Gopichand did not stop there; he also pursued a doctorate in economics from Richmond College, London, and then took steps towards starting his own business. Under his leadership, the Hinduja Group acquired Gulf Oil in 1984, and just three years later, also acquired Ashok Leyland. Gopichand currently resides in London, while his younger brother Prakash lives in Monaco, and the youngest brother Ashok stays in Mumbai overseeing Indian businesses.
The Hinduja family had to go through a rough phase when a dispute over property among the Hinduja brothers started. It continued for a long time and finally in November 2022, the Hinduja brothers decided to end the dispute. The brothers agreed to halt the lawsuits ongoing across Europe and deemed it appropriate to work together.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
40 minutes ago
- Business Standard
Indian pharma market grows 7.2% in May led by chronic therapies
Indian pharma market grew 7.2% in May with strong performance in chronic therapies such as cardiac and anti-infectives, along with gains from price hikes and new launches Sanket Koul New Delhi The Indian Pharma Market (IPM) grew 7.2 per cent in May this year with almost all major therapies showing positive growth, according to market research firm Pharmarack. Data suggest that big chronic therapies such as cardiac and anti-infectives, which account for nearly 25 per cent of the overall domestic market, recorded value growth of 11.7 per cent and 7.6 per cent, respectively. On the other hand, several smaller supergroups such as urology and antineoplastics, which made up 2 per cent each of the IPM's sales value for the month, also recorded double-digit growth in May at 12.3 per cent and 11.7 per cent, said Sheetal Sapale, vice-president, commercial, Pharmarack. Data suggest that the overall value growth for the IPM in May was driven by price growth and new introductions. The IPM also reported a minuscule 0.4 per cent unit growth during the month, with the chronic segments such as antidiabetics (6.1 per cent) and cardiac (4.8 per cent) performing better than the overall market figure. Experts believe that the antidiabetic segment saw a 6.1 per cent rise in volume in May due to a key drug, empagliflozin, going off-patent, as companies launched several plain and combination medications in the segment. Growth in the moving annual turnover (MAT) for the IPM between June 2024 and May 2025 stood at 8.1 per cent, leading to a total turnover of over Rs 2.29 trillion, while volumes in the domestic market grew by 1.1 per cent. The MAT of leading therapy areas such as cardiac, gastrointestinal and anti-infectives, which constitute around 38 per cent of the pharmaceutical market, showed robust volume growth at 10.4 per cent, 9.5 per cent and 6.5 per cent, respectively. While the top 20 brands in the IPM registered modest monthly value growth in the domestic market during the month, Sun Pharma and Dr Reddy's posted significant monthly value growth at 11.2 per cent each. They were followed by Torrent Pharma and Ipca Laboratories at 10.8 per cent, and Alkem Laboratories at 10.3 per cent monthly value growth. According to Pharmarack data, GlaxoSmithKline's (GSK) antibiotic medication Augmentin and USV's anti-diabetic drug Glycomet GP continued to be the top-selling medicine brands at the MAT level, with sales worth Rs 819 crore and Rs 810 crore, respectively.
The Hindu
an hour ago
- The Hindu
Navy to commission Anti-Submarine Warfare Shallow Water Craft on June 18
The Indian Navy is all set to commission its Anti-Submarine Warfare Shallow Water Craft (ASW-SWC) Arnala at the Naval Dockyard in Visakhapatnam on June 18. The event will mark the formal induction of the first of 16 ASW-SWC-class ships into the Navy. Designed and constructed by Garden Reach Shipbuilders & Engineers (GRSE), Kolkata, under a public-private partnership with L&T Shipbuilders, Arnala was a 'testament to the success of the Aatmanirbhar Bharat (self-reliant India) initiative in defence manufacturing', a release said. 'Constructed under the guidance of the Directorate of Ship Production and oversight of the Warship Overseeing Teams in Kolkata and Kattupalli, Arnala was delivered to the Indian Navy on May 8, 2025,' said a release. The commissioning ceremony will be presided over by Chief of Defence Staff General Anil Chauhan. It will be hosted by Vice-Admiral Rajesh Pendharkar, Flag Officer Commanding-in-Chief, Eastern Naval Command. The warship incorporates more than 80% indigenous content and integrates advanced systems from leading Indian defence firms, including Bharat Electronics Limited, L&T, Mahindra Defence, and MEIL. The project has engaged over 55 Micro, Small, and Medium Enterprises (MSMEs). Designed for a range of anti-submarine warfare operations, Arnala is equipped to conduct sub-surface surveillance, search and rescue missions, and low-intensity maritime operations. The 77-metre-long warship, with a gross tonnage of over 1,490 tonnes, is the largest Indian naval warship to be propelled by a diesel engine-waterjet combination. 'The commissioning of Arnala will mark a transformative moment in India's naval capabilities, strengthening coastal defence and reaffiliate India's position as a self-reliant maritime power in the strategically vital Indian Ocean Region,' it said, adding that it has been named after the historic Arnala Fort off Vasai, Maharashtra. Constructed in 1737 by the Marathas under the leadership of Chimaji Appa, the fort was strategically positioned to oversee the Vaitarna river's mouth, serving as a lookout post over the northern Konkan coast. The crest of Arnala features a stylised auger shell set against a blue backdrop, with the ship's name inscribed in Devanagari script at the base. 'The Auger Shell, known for its spiralled, reinforced structure and precision tip, symbolises resilience, vigilance, survival, and dominance in challenging environments, which mirrors the essence of the ship built to withstand the relentless forces of the ocean and undertake flawless anti-submarine operations with precise ordnance on target,' said an official.
Mint
an hour ago
- Mint
UK watchdog pushes Amazon to rein in misleading product ratings: Know what happened
Amazon has pledged to step up its efforts in tackling fake reviews after reaching an agreement with the UK's competition watchdog, the Competition and Markets Authority (CMA). The commitment follows a CMA investigation launched in 2021 to scrutinise whether major online platforms like Amazon and Google were adequately protecting consumers from misleading online ratings. The probe was prompted by the sharp rise in online shopping during the COVID-19 pandemic, which exposed widespread manipulation of product reviews. You may be interested in Under the agreement, Amazon has vowed to enhance its systems aimed at detecting and removing fake reviews. This includes clamping down on a practice known as "catalogue abuse", where sellers artificially boost the reputation of a product by linking it to positive reviews meant for entirely different items. The CMA highlighted a common example of this tactic: shoppers may see a pair of headphones with an impressive five-star rating, only to discover that the reviews actually refer to a mobile phone charger. Amazon will now take stronger action against those engaging in such deceptive practices, including banning businesses from selling on its platform and prohibiting users who repeatedly post fake reviews. Sarah Cardell, Chief Executive of the CMA, emphasised the significance of trustworthy reviews. 'Millions of people shop on Amazon, and star ratings and reviews play a crucial role in what they choose to buy. These undertakings mean shoppers can be more confident that what they see is genuine and that those trying to mislead them will face serious consequences,' she said. This move builds on a similar undertaking secured from Google earlier this year, as part of the CMA's wider effort to ensure online platforms take greater responsibility for protecting consumers. In a statement, Amazon reaffirmed its 'zero tolerance' stance on fake reviews and said the new measures complement its current initiatives. 'We invest substantial resources in preventing fake reviews from appearing in our store, including expert investigators and machine learning tools that analyse thousands of data points to detect suspicious activity,' the company stated. The new commitments apply specifically to Amazon's UK website and are intended to align the company more closely with British consumer protection laws.
